1. Home
  2. AVTX vs BRID Comparison

AVTX vs BRID Comparison

Compare AVTX & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • BRID
  • Stock Information
  • Founded
  • AVTX 2011
  • BRID 1932
  • Country
  • AVTX United States
  • BRID United States
  • Employees
  • AVTX N/A
  • BRID N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • BRID Specialty Foods
  • Sector
  • AVTX Health Care
  • BRID Consumer Staples
  • Exchange
  • AVTX Nasdaq
  • BRID Nasdaq
  • Market Cap
  • AVTX 88.4M
  • BRID 93.2M
  • IPO Year
  • AVTX 2015
  • BRID N/A
  • Fundamental
  • Price
  • AVTX $7.35
  • BRID $10.31
  • Analyst Decision
  • AVTX Strong Buy
  • BRID
  • Analyst Count
  • AVTX 4
  • BRID 0
  • Target Price
  • AVTX $33.00
  • BRID N/A
  • AVG Volume (30 Days)
  • AVTX 54.4K
  • BRID 1.5K
  • Earning Date
  • AVTX 03-28-2025
  • BRID 03-07-2025
  • Dividend Yield
  • AVTX N/A
  • BRID N/A
  • EPS Growth
  • AVTX N/A
  • BRID N/A
  • EPS
  • AVTX N/A
  • BRID N/A
  • Revenue
  • AVTX $820,000.00
  • BRID $223,645,000.00
  • Revenue This Year
  • AVTX N/A
  • BRID N/A
  • Revenue Next Year
  • AVTX N/A
  • BRID N/A
  • P/E Ratio
  • AVTX N/A
  • BRID N/A
  • Revenue Growth
  • AVTX N/A
  • BRID N/A
  • 52 Week Low
  • AVTX $4.18
  • BRID $7.77
  • 52 Week High
  • AVTX $34.46
  • BRID $14.69
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 42.79
  • BRID 49.20
  • Support Level
  • AVTX $7.42
  • BRID $10.28
  • Resistance Level
  • AVTX $8.50
  • BRID $10.51
  • Average True Range (ATR)
  • AVTX 0.64
  • BRID 0.13
  • MACD
  • AVTX 0.02
  • BRID -0.02
  • Stochastic Oscillator
  • AVTX 17.16
  • BRID 47.50

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are processing and distribution of frozen products, and processing and distribution of snack food products. It includes products such as biscuits, bread dough items, roll dough items, dry sausage products, and beef jerky. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. It derives a majority of its revenue from snack food products.

Share on Social Networks: